Investment Rating - The industry rating is optimistic, expecting an overall return exceeding 5% above the CSI 300 index in the next six months [9]. Core Insights - The report highlights the rapid commercialization of exoskeleton robots, which are transitioning from specialized medical devices to applications in industrial production, outdoor activities, military training, and elder care [6]. - The global exoskeleton robot market is projected to grow significantly, with an estimated market size of USD 1.8 billion in 2024 and expected to exceed USD 12 billion by 2030, reflecting a compound annual growth rate (CAGR) of 28% [6]. - The report notes that China's "14th Five-Year Plan" includes exoskeletons as a key development area in high-end medical equipment, with some rehabilitation exoskeletons already covered by health insurance [6]. Market Performance - As of May 21, 2025, the CSI 300 index rose by 0.47%, while the machinery sector declined by 0.75%, ranking 26th among all primary industries [3]. - Within the sub-industries, lithium battery equipment saw the highest increase at 1.94%, while semiconductor equipment experienced the largest decline at 1.30% [3]. - Notable stock performances included Xunbang Intelligent (+19.99%), Zhongyou Technology (+18.18%), and Meilun Elevator (+9.99%), while Hengerd (-11.93%), Xinlong Health (-9.95%), and Shenghui Integration (-9.82%) faced significant declines [3]. Company Announcements - Jiangsu Shentong's major shareholder reduced their stake by 3% from 6.91% [4]. - Delong Laser's major shareholder plans to reduce their stake by 3% from 12.09% [4]. - Duopule's major shareholder intends to reduce their stake by 4.85% from 9.33% [4]. - Yilida has repurchased 0.0706% of its total share capital through a stock buyback [4].